Angiotensin-converting enzyme inhibitors and angiotensin receptor blockers may be harmful in patients with diabetes during COVID-19 pandemic

The novel coronavirus disease 2019 (COVID-19) outbreak once again demonstrated the importance of the renin-angiotensin system (RAS) in patients with diabetes. Activation of the RAS increases in patients with diabetes. The virus attaches to the ACE2 enzyme at low cytosolic pH values and enters into t...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	Diabetes & metabolic syndrome clinical research & reviews 2020-07, Vol.14 (4), p.349-350
Hauptverfasser:	Cure, Erkan, Cumhur Cure, Medine
Format:	Artikel
Sprache:	eng
Schlagworte:	Angiotensin converting enzyme inhibitors Angiotensin I Angiotensin II - metabolism Angiotensin receptor antagonists Angiotensin Receptor Antagonists - adverse effects Angiotensin-Converting Enzyme 2 Angiotensin-Converting Enzyme Inhibitors - adverse effects Betacoronavirus - metabolism Coronavirus Infections - epidemiology Coronavirus Infections - mortality COVID-19 Diabetes mellitus Diabetes Mellitus - drug therapy Heart - virology Humans Hydrogen-Ion Concentration Novel coronavirus disease 2019 (COVID-19) Pandemics Peptide Fragments Peptidyl-Dipeptidase A - metabolism Pneumonia, Viral - epidemiology Pneumonia, Viral - mortality Renin-angiotensin system SARS-CoV-2
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Schreiben Sie den ersten Kommentar!